Related Experiment Video
Updated: Dec 31, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
788
Acute Aortic Dissection Surgery: Hybrid Debranching Versus Total Arch Replacement
1Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Journal of Cardiothoracic and Vascular Anesthesia
|January 6, 2020
Summary
For patients over 60 with acute Stanford type A aortic dissection (AAAD), hybrid debranching surgery offers better outcomes than total arch replacement (TAR), including shorter hospital stays and improved survival. Outcomes were similar for patients under 60.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Aortic Dissection Treatment
Background:
- Acute Stanford type A aortic dissection (AAAD) is a life-threatening condition requiring prompt surgical intervention.
- The optimal surgical strategy, particularly comparing hybrid debranching and total arch replacement (TAR), remains debated across different age demographics.
Purpose of the Study:
- To compare the clinical outcomes of hybrid debranching versus total arch replacement (TAR) in patients with acute Stanford type A aortic dissection (AAAD).
- To analyze the efficacy of these strategies across different age groups, specifically focusing on patients aged 60 years and older versus those younger than 60.
Main Methods:
- A retrospective analysis was conducted at a single university medical center.
- 309 patients with AAAD who underwent either hybrid debranching or TAR surgery between 2017 and 2019 were included.
- Exclusion criteria included specific aortic landing zones, concomitant valve/coronary operations, staged TEVAR, and organ ischemia.
Main Results:
- In patients ≥60 years, hybrid debranching was associated with significantly shorter hospital stays (22.3 vs 28.6 days), lower rates of neurologic events (5.2% vs 16.7%), and reduced renal insufficiency (5.2% vs 23.8%) compared to TAR.
- Mid-term survival was higher in the hybrid group for patients ≥60 years (95.1% vs 65.2%).
- No significant differences in outcomes were observed between hybrid debranching and TAR for patients <60 years.
Conclusions:
- Hybrid debranching surgery demonstrates superior outcomes for older patients (≥60 years) with AAAD, including reduced complications and improved survival.
- For younger patients (<60 years), both hybrid debranching and TAR yield comparable results.
- Hybrid debranching presents a promising alternative surgical option for elderly patients diagnosed with AAAD.

